Aldeyra Therapeutics Inc (ALDX) Unusual Options Activity Today

Checking ALDX unusual options activity helps you spot when traders are making outsized bets on Aldeyra Therapeutics Inc before the broader market catches on. Aldeyra Therapeutics Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ALDX unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ALDX unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ALDX unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ALDX unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It also develops ADX-629, a first-in-class orally administered RASP modulator that is Phase II clinical trial for psoriasis, asthma, and COVID-19; and ADX-2191, a dihydrofolate reductase inhibitor which is in phase 3 for the prevention of proliferative vitreoretinopathy, and phase II clinical trial for the treatment of retinitis pigmentosa, as well as for treating primary vitreoretinal lymphoma.

The company has a license agreement with Madrigal Pharmaceuticals, Inc. for developing ADX-1612, which inhibits the protein chaperome for the treatment of inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was incorporated in 2004 and is based in Lexington, Massachusetts.

Catalysts rarely arrive without a footprint, and ALDX unusual options activity is often where that footprint shows up first. Our scanner tracks Aldeyra Therapeutics Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ALDX unusual options volume on the call side or chasing put sweeps, Aldeyra Therapeutics Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.